O43526 (KCNQ2_HUMAN) Homo sapiens (Human)
Potassium voltage-gated channel subfamily KQT member 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
21 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| human KCNQ2-CaM-Ebio1 complex in the presence of PIP2 |
Heteromer P0DP23; | 100.0 | 4×7PN; | |||
| human KCNQ2-CaM in complex with PIP2 and HN37 |
Heteromer P0DP23; | 100.0 | 4×9MF; 4×PIO; | |||
| Human KCNQ2-CaM-Ebio2 Complex in the Presence of PIP2 |
Heteromer P0DP25; | 100.0 | 4×A1L3C; 4×PIO; | |||
| human KCNQ2-CaM in complex with retigabine |
Heteromer P0DP25; | 100.0 | 4×FBX; | |||
| Human KCNQ2(F104A)-CaM-PIP2-CBD complex in state II |
Heteromer P0DP23; | 99.72 | 4×P0T; 4×PIO; | |||
| Human KCNQ2-CaM in complex with CBD and PIP2 |
Heteromer P0DP23; | 100.0 | 8×P0T; 4×PIO; | |||
| human KCNQ2-CaM-Ebio3 Complex in the Presence of PIP2 |
Heteromer P0DP23; | 100.0 | 4×A1L3D; | |||
| human KCNQ2-CaM in apo state |
Heteromer P0DP25; | 100.0 | ||||
| Human KCNQ2(F104A)-CaM-PIP2-CBD complex in state I |
Heteromer P0DP23; | 99.7 | 4×P0T; | |||
| human KCNQ2-CaM-Ebio1-S1 complex in the presence of PIP2 |
Heteromer P0DP23; | 100.0 | 4×7Q0; | |||
| Human KCNQ2-CaM complex in the presence of PIP2 |
Heteromer P0DP23; | 100.0 | ||||
| human KCNQ2-CaM in complex with ztz240 |
Heteromer P0DP25; | 100.0 | 4×GB9; | |||
| Human KCNQ2-CaM in complex with QO-83 |
Heteromer P0DP23; | 100.0 | 4×A1LWZ; | |||
| Human KCNQ2-CaM in complex with CBD |
Heteromer P0DP23; | 100.0 | 8×P0T; | |||
| Human KCNQ2-CaM-HN37 complex in the presence of PIP2 |
Heteromer P0DP23; | 100.0 | 8×9MF; | |||
| Solution Structure of CaM/Kv7.2-hAB Complex |
Heteromer P0DP23; | 100 | 2×CA; | |||
| Solution Structure of CaM/Kv7.2-hAB Complex |
Heteromer P0DP23; | 100 | 4×CA; | |||
| human KCNQ2 in apo state | homo-4-mer | 100.0 | ||||
| Human KCNQ2-CaM in complex with HN37 | homo-4-mer | 100.0 | 8×9MF; | |||
| human KCNQ2 in complex with retigabine | homo-4-mer | 100.0 | 4×FBX; | |||
| human KCNQ2 in complex with ztz240 | homo-4-mer | 100.0 | 4×GB9; | |||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 100.00 | ||
| 8xo1.1.A | monomer | 0.59 | 100.00 | |||
| 8w4u.1.B | monomer | 0.57 | 100.00 | |||
| 8v64.1.A | homo-4-mer | 0.52 | 3×K; | 20.69 | ||
18 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.68 | ||
| Isoform 2 | 8w4u.1.B | monomer | 0.59 | 99.68 | |||
| Isoform 2 | 8xo1.1.A | monomer | 0.58 | 99.77 | |||
| Isoform 2 | 8v64.1.A | homo-4-mer | 0.53 | 3×K; | 20.69 | ||
| Isoform 3 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.18 | ||
| Isoform 3 | 8j05.1.D | monomer | 0.58 | 99.18 | |||
| Isoform 3 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | |||
| Isoform 4 | 8izy.1.A | homo-4-mer | 0.71 | 8×9MF; | 99.83 | ||
| Isoform 4 | 8xo1.1.A | monomer | 0.60 | 99.88 | |||
| Isoform 4 | 8w4u.1.B | monomer | 0.59 | 99.83 | |||
| Isoform 4 | 7yo2.1.A | homo-4-mer | 0.52 | 20.69 | |||
| Isoform 5 | 8izy.1.A | homo-4-mer | 0.70 | 4×9MF; | 99.51 | ||
| Isoform 5 | 8w4u.1.B | monomer | 0.58 | 99.51 | |||
| Isoform 5 | 8xo1.1.A | monomer | 0.57 | 99.76 | |||
| Isoform 5 | 7yo2.1.A | homo-4-mer | 0.53 | 21.52 | |||
| Isoform 6 | 8izy.1.A | homo-4-mer | 0.73 | 8×9MF; | 99.67 | ||
| Isoform 6 | 8xo1.1.A | monomer | 0.72 | 99.47 | |||
| Isoform 6 | 8v64.1.A | homo-4-mer | 0.52 | 3×K; | 20.69 | ||